Elliott S. Lichtstein, MD

Elliott Lichtstein, MD
Interventional Cardiology
Valley Medical Group
Member, ColigoCare
ColigoCare is a network of physicians working collectively to provide the highest quality care to patients and the community.


VMG Cardiology, Westwood

333 Old Hook Road
Suite 200
Westwood, NJ 07675
Phone: 201-664-0201
Fax: 201-666-7970



MD, Temple University School Of Medicine, 1977 - 1981

BA, Univ Of Rochester School Of Medicine, 1974 - 1977


Long Island Jewish-Hillside Medical Center, Cardiology, 1984 - 1986

Internship & Residency

Albany Medical Center, Internal Medicine, 1981 - 1984

Board Certifications

American Board Of Internal Medicine - Certified, 1984

Subspecialty Board Of Cardiovascular Disease - Certified, 1987

Get to Know Me

What are some of the specific conditions you treat?

Coronary artery disease, myocardial infarction, atrial fibrillation, congestive heart failure, palpitations, hypertension, arrhythmias, pacemaker management, edema, aortic valve disease, mitral valve disease, mitral valve prolapse, aortic aneurysm, PAD-peripheral artery disease, lipid disorders, elevated cholesterol.

What techniques or procedures do you use in your practice?

We care for our patients with the latest techniques in cardiac diagnosis including noninvasive and invasive modalities.

Describe some of your professional highlights.

  • Fellow of the American College of Cardiology.
  • Board certified in internal medicine, cardiovascular diseases.
  • Board certified in invasive cardiology.

Publications & Research

Clinical Trials


A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease.


A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome.

Cardiovascular Inflammation Reduction Trial (CIRT)

The Cardiovascular Inflammation Reduction Trial (CIRT) is a randomized clinical trial investigating whether taking low-dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages. This trial is funded by the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH).


Valley Medical Group providers accept the following plans.